Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Taxes (2022 - 2026)

Sunshine Biopharma filings provide 4 years of Change in Taxes readings, the most recent being -$152874.0 for Q4 2025.

  • On a quarterly basis, Change in Taxes fell 81.02% to -$152874.0 in Q4 2025 year-over-year; TTM through Sep 2025 was $68422.0, a 75.85% decrease, with the full-year FY2024 number at -$812080.0, down 1008.69% from a year prior.
  • Change in Taxes hit -$152874.0 in Q4 2025 for Sunshine Biopharma, down from $162992.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $1.0 million in Q4 2023 to a low of -$1.2 million in Q2 2024.
  • Median Change in Taxes over the past 4 years was -$40161.0 (2025), compared with a mean of -$49742.2.
  • Biggest five-year swings in Change in Taxes: skyrocketed 323.55% in 2023 and later tumbled 530.84% in 2024.
  • Sunshine Biopharma's Change in Taxes stood at $238679.0 in 2022, then skyrocketed by 323.55% to $1.0 million in 2023, then plummeted by 108.35% to -$84452.0 in 2024, then tumbled by 81.02% to -$152874.0 in 2025.
  • The last three reported values for Change in Taxes were -$152874.0 (Q4 2025), $162992.0 (Q3 2025), and $30043.0 (Q2 2025) per Business Quant data.